Cargando…
Fingolimod-induced decrease in heart rate may predict subsequent decreasing degree of lymphocytes
Here, we determined whether degree of decreased heart rate due to fingolimod treatment correlates with decreasing degree of lymphocytes in relapse-remitting multiple sclerosis (RRMS). In total, 30 patients with RRMS were treated with 0.5 mg fingolimod and their heart rate recorded every 30 minutes f...
Autores principales: | Ikeda, Tokunori, Kakuma, Tatsuyuki, Watari, Mari, Ando, Yukio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219537/ https://www.ncbi.nlm.nih.gov/pubmed/30401975 http://dx.doi.org/10.1038/s41598-018-34797-7 |
Ejemplares similares
-
Author Correction: Fingolimod-induced decrease in heart rate may predict subsequent decreasing degree of lymphocytes
por: Ikeda, Tokunori, et al.
Publicado: (2019) -
Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment
por: Suenaga, Genki, et al.
Publicado: (2016) -
Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions
por: Muris, Anne-Hilde, et al.
Publicado: (2014) -
Dexmedetomidine may decrease the bupivacaine toxicity to heart
por: Jin, Zhousheng, et al.
Publicado: (2021) -
Decreased Heart Rate Variability in COVID-19
por: Yin, Chengfen, et al.
Publicado: (2022)